• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[溶液环境对百日咳毒素纯化的影响]

[Effect of solution environment on the purification of pertussis toxin].

作者信息

Wu Tie, Bi Jingxiu, Huang Yongdong, Zhang Yan, Sun Lijing, Sun Chunbao, Su Zhiguo

机构信息

Civil & Environmental Engineering School, University of Science and Technology ofBeijing, Beijing 100083, China.

出版信息

Sheng Wu Gong Cheng Xue Bao. 2008 Jul;24(7):1279-84. doi: 10.1016/s1872-2075(08)60061-8.

DOI:10.1016/s1872-2075(08)60061-8
PMID:18837409
Abstract

The low recovery of pertussis toxin (PT) and the low resolving efficiency of chromatography, due to the instability of PT in low salt condition, are the main challenges for its purification. We aplied 2 mol/L urea to prevent the aggregation and disassociation of PT during the purification by ion-exchange chromatography (IEC) and gel filtration chromatography (GFC). The effect of urea on the purification of PT was studied by ELISA assay and non-reduced SDS-PAGE. The activity recoveries of PT and filamentous hemagglutinin (FHA) in IEC and GFC, the resolution efficiency in GFC and the purities of PT and FHA were improved obviously by adding 2 mol/L urea in the mobile phase. The results highlight the potential application of urea in the acellular pertussis vaccine (APV) manufacture procedure.

摘要

由于百日咳毒素(PT)在低盐条件下不稳定,导致其回收率低以及色谱分离效率低,这是其纯化过程中的主要挑战。我们应用2 mol/L尿素来防止PT在离子交换色谱(IEC)和凝胶过滤色谱(GFC)纯化过程中的聚集和解离。通过ELISA测定和非还原SDS-PAGE研究了尿素对PT纯化的影响。在流动相中添加2 mol/L尿素后,IEC和GFC中PT和丝状血凝素(FHA)的活性回收率、GFC中的分离效率以及PT和FHA的纯度均得到明显提高。结果突出了尿素在无细胞百日咳疫苗(APV)生产过程中的潜在应用。

相似文献

1
[Effect of solution environment on the purification of pertussis toxin].[溶液环境对百日咳毒素纯化的影响]
Sheng Wu Gong Cheng Xue Bao. 2008 Jul;24(7):1279-84. doi: 10.1016/s1872-2075(08)60061-8.
2
The purification and characterization of an acellular pertussis vaccine.一种无细胞百日咳疫苗的纯化与特性分析
J Biol Stand. 1988 Apr;16(2):83-9. doi: 10.1016/0092-1157(88)90035-2.
3
Purification design and practice for pertactin, the third component of acellular pertussis vaccine, from Bordetella pertussis.百日咳杆菌无细胞百日咳疫苗第三组分百日咳黏附素的纯化设计与实践
Vaccine. 2016 Jul 25;34(34):4032-9. doi: 10.1016/j.vaccine.2016.06.029. Epub 2016 Jun 11.
4
A novel process for preparing an acellular pertussis vaccine composed of non-pyrogenic toxoids of pertussis toxin and filamentous hemagglutinin.一种制备无细胞百日咳疫苗的新方法,该疫苗由百日咳毒素的无热原类毒素和丝状血凝素组成。
Mol Immunol. 1991 Mar;28(3):251-5. doi: 10.1016/0161-5890(91)90070-z.
5
Rapid purification of pertussis toxin (PT) and filamentous hemagglutinin (FHA) by cation-exchange chromatography.通过阳离子交换色谱法快速纯化百日咳毒素(PT)和丝状血凝素(FHA)。
Vaccine. 2004 Mar 29;22(11-12):1570-5. doi: 10.1016/j.vaccine.2003.09.040.
6
Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin.柱纯化百日咳毒素与丝状血凝素联合制备的无细胞百日咳疫苗的特性及临床研究
Tokai J Exp Clin Med. 1988;13 Suppl:59-69.
7
Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers.对1988年由6家日本制造商制备的日本无细胞百日咳疫苗的进一步特性分析。
Tokai J Exp Clin Med. 1988;13 Suppl:79-88.
8
Engineering bacterial toxin for the development of new vaccine against pertussis.改造细菌毒素以研发新型百日咳疫苗。
Tokai J Exp Clin Med. 1988;13 Suppl:217-22.
9
Characterization of co-purified acellular pertussis vaccines.共纯化无细胞百日咳疫苗的特性分析
Hum Vaccin Immunother. 2015;11(2):421-7. doi: 10.4161/21645515.2014.988549.
10
Quantification of pertussis toxin, filamentous haemagglutinin, 69 kDa outer membrane protein, agglutinogens 2 and 3 and lipopolysaccharide in the Danish whole-cell pertussis vaccine.丹麦全细胞百日咳疫苗中百日咳毒素、丝状血凝素、69 kDa外膜蛋白、凝集原2和3以及脂多糖的定量分析。
Vaccine. 1993;11(3):318-22. doi: 10.1016/0264-410x(93)90193-2.